Drug Search Results
More Filters [+]

Dextofisopam

Alternative Names: dextofisopam
Latest Update: 2024-04-19
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Pharmos
Company Location: NORTH LAS VEGAS NV 89084
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dextofisopam

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Irritable Bowel Syndrome

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

VPI-TOFP-203

P2

Completed

Irritable Bowel Syndrome

2009-09-01

Recent News Events